Technical Report on Pricing of cancer medicines and its impacts

Overview

To prepare a comprehensive technical report to the Executive Board at its 144th session that examines pricing approaches , including transparency , and their impact on availability and affordability of medicines for the prevention and treatment of cancer, including any evidence of the benefits or unintended negative consequences , as well as incentives for investment in research and development on cancer and innovation of these measures, as well as the relationship between inputs throughout the value chain and price setting , financing gaps for research and development on cancer, and options that might enhance the affordability and accessibility of these medicines.